Innate immune mechanisms for recognition and uptake of Candida species

Trends in Immunology

Volumn 31, Issue 9, 2010, Pages 346-353

  Netea, Mihai G ^a   Maródi, László ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CD36 ANTIGEN; CD37 ANTIGEN; CRYOPYRIN; DECTIN 1; DECTIN 2; GALECTIN 3; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 22; MANNOSE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN RECEPTOR;

ANTIFUNGAL ACTIVITY; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CANDIDA ALBICANS; CYTOKINE PRODUCTION; FUNGAL LIFE CYCLE STAGE; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HYPER IGE SYNDROME; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; MUCOCUTANEOUS CANDIDIASIS; MYCOBACTERIUM; NEUTROPHIL; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTOSIS; PROTEIN DEFICIENCY; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; SPECIES INVASION; STAPHYLOCOCCUS AUREUS; TH17 CELL; TRICHOPHYTON RUBRUM; ANIMAL; CANDIDA; CANDIDIASIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY;

ANIMALS; CANDIDA; CANDIDIASIS; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; RECEPTORS, IMMUNOLOGIC;

EID: 77956185307     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.06.007     Document Type: Review

References (88)

1. Neofytos D., et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl. Infect. Dis. 2010, 12:220-229.
2. Pfaller M.A., Diekema D.J. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 2010, 36:1-53.
3. Lilic D., Haynes K. Candida. Immunology of Fungal Infections 2007, 359-380. Springer. G.D. Brown, M.G. Netea (Eds.).
4. Maródi L. Local and systemic host defense mechanisms against Candida: immunopathology of candidal infections. Pediatr. Infect. Dis. J. 1997, 16:795-801.
5. Maródi L., Johnston R.B. Invasive Candida species disease in infants and children: occurrence, risk factors, management, and innate host defense mechanisms. Curr. Opin. Pediatr. 2007, 19:693-697.
6. Jeneway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
7. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 18:819-826.
8. Maródi L., et al. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 1991, 146:2783-2789.
9. Gazi U., et al. Influence of the mannose receptor in host immune responses. Immunbiology 2009, 214:554-561.
10. Gantner B.N., et al. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 2003, 197:1107-1117.
11. Reid D.M., et al. Pattern recognition: recent insights from Dectin-1. Curr. Opin. Immunol. 2009, 21:30-37.
12. Akira S., et al. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
13. Lemaitre B., et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifugal response in Drosophila adults. Cell 1996, 86:973-983.
14. Rock F.L., et al. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:588-593.
15. Wang J.E., et al. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect. Immun. 2001, 69:2402-2406.
16. Villamón E., et al. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect. 2004, 6:1-7.
17. Netea M.G., et al. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 2002, 185:1483-1489.
18. Jouault T., et al. Candida albicans phospholipomannan is sensed through Toll-like receptors. J. Infect. Dis. 2003, 188:165-172.
19. Bellocchio S., et al. The contribution of the Toll-like/IL-1 receptor suprerfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 2004, 172:3059-3069.
20. Netea M.G., et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 2004, 172:3712-3718.
21. Blasi E., et al. Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans. FEMS Immunol. Med. Microbiol. 2005, 44:69-79.
22. Sutmuller R.P., et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 2006, 116:485-494.
23. Netea M.G., et al. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. FEMS Immunol. Med. Microbiol. 2008, 52:118-123.
24. Poltorak A., et al. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in TIr4 gene. Science 1998, 282:2085-2088.
25. Tada H., et al. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol. Immunol. 2002, 46:503-512.
26. Netea M.G., et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 2006, 116:1642-1650.
27. Murciano C., et al. Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med. Mycol. 2006, 44:149-157.
28. Netea, M.G. et al., (2010) Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors. Med. Mycol. DOI.
29. Miyazato A., et al. Toll-like receptor 9-dependent activation of myeloid dendritic cells by deoxynucleic acids from Candida albicans. Infect. Immun. 2009, 77:3056-3064.
30. van de Veerdonk F.L., et al. Redundant role of TLR9 for anti-Candida host defense. Immunobiology 2008, 213:613-620.
31. Zelensky A.N., et al. The C-type lectin-like domain superfamily. FEBS J. 2005, 272:6179-6217.
32. Brown G.D. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 2006, 6:33-43.
33. Ip W.K., et al. Mannose-binding lectin and innate immunity. Immunol. Rev. 2009, 230:9-21.
34. Stahl P.D., et al. Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:1399-1403.
35. Stahl P.D., et al. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 1998, 10:50-55.
36. Maródi L., et al. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J. Immunol. 1994, 153:5643-5649.
37. Ezekowitz R.A., et al. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med. 1990, 172:1785-1794.
38. Heinsbroek S.E., et al. Stage-specific sampling by pattern recognition receptors during Candida albicans phagocytosis. PLoS Pathog. 2008, 4:e1000218.
39. van de Veerdonk F.L., et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009, 5:329-340.
40. Lee S.J., et al. Normal host defense during systemic candidiasis in mannose receptor-deficient mice. Infect. Immun. 2003, 71:437-445.
41. LeibundGut-Landmann S., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8:630-638.
42. Gringhuis S.I., et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat. Immunol. 2009, 10:203-213.
43. Gow N.A., et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J. Infect. Dis. 2007, 196:1565-1571.
44. Brown G.D., et al. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 2003, 197:1119-1124.
45. Dennehy K.M., et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur. J. Immunol. 2008, 38:500-506.
46. Ferwerda G., et al. Dectin-1 synergize with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol. 2008, 10:2058-2066.
47. van Spriel A.B., et al. The tetraspanin protein CD37 regulates IgA responses and antifungal immunity. PLoS Pathog. 2009, 5:e1000338.
48. Taylor P.R., et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 2007, 8:31-38.
49. Saijo S., et al. Dectin-1 required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 2007, 8:39-46.
50. Gross O., et al. Card9 controls a non-TLR signalling pathway for innate antifungal immunity. Nature 2006, 442:651-656.
51. van Bruggen R., et al. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol. Immunol. 2009, 47:575-581.
52. Klis F.M., et al. Molecular organization of the cell wall of Candida albicans. Med. Mycol. 2001, 39:1-8.
53. Gantner B.N., et al. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 2005, 24:1277-1286.
54. Maródi L., et al. Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 1998, 66:2750-2754.
55. Hohl T.M., et al. Cracking the fungal armour. Nat. Med. 2006, 12:730-732.
56. Wheeler R.T., et al. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog. 2006, 2:328-339.
57. Ariizumi K., et al. Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms. J. Biol. Chem. 2000, 275:11957-11963.
58. McGreal E.P. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 2006, 16:422-430.
59. Sato K., et al. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J. Biol. Chem. 2006, 281:38854-38866.
60. Robinson M.J., et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 2009, 206:2037-2051.
61. Koppel E.A., et al. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGN1 in pathogen recognition and immune regulation. Cell Microbiol. 2005, 7:157-165.
62. Cambi A., et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 2003, 33:532-538.
63. Geijtenbeek T.B., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 2003, 197:7-17.
64. Matsumoto M., et al. A novel LPS-inducable C-type lectin is a transcriptional target of NF-IL6 in macrophages. J. Immunol. 1999, 163:5039-5048.
65. Wells C.A., et al. The macrophage-inducible C-type lectin, Mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 2008, 180:7404-7413.
66. Means T.K., et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 2009, 206:637-653.
67. Jouault T., et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signalling. J. Immunol. 2006, 177:4679-4687.
68. Jawhara S., et al. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J. Infect. Dis. 2008, 197:972-980.
69. Kilpatrick D.C. Mann-binding lectin: clinical significance and applications. Biochim. Biophys. Acta 2002, 1572:401-413.
70. Brouwer N., et al. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding. J. Immunol. 2008, 180:4124-4132.
71. Kozel T.R., et al. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect. Immun. 1996, 64:3360-3368.
72. Martinon F., et al. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004, 117:561-574.
73. Vonk A.G., et al. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J. Infect. Dis. 2006, 193:1419-1426.
74. Mencacci A., et al. Interleukin 18 restores defective Th1 immunity to candida albicans in caspase 1-deficient mice. Infect. Immun. 2000, 68:5126-5131.
75. Gross O., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for antifungal host defence. Nature 2009, 459:433-436.
76. Kumar J., et al. Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J. Immunol. 2009, 183:8061-8067.
77. Hise A.G., et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009, 5:487-497.
78. Hasegawa M., et al. ASC-mediated NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP. J. Biol. Chem. 2005, 280:15122-15130.
79. van den Graaf C.A., et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine Network 2006, 17:29-34.
80. Woehrle T., et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine 2008, 41:322-329.
81. Ferwerda B., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 2009, 361:1760-1767.
82. Plantinga T.S., et al. Early stop polymorphism in human DECTIN-1 is associated with increased Candida colonization in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2009, 49:724-732.
83. Glocker E.O., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 2009, 361:1727-1735.
84. Milner J.D. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
85. van de Veerdonk F.L., et al. Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency. Clin. Exp. Immunol. 2009, 159:57-64.
86. Jiao H., et al. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol. Immunol. 2008, 46:202-206.
87. Puel A., et al. Auto-antibodies to IL-17A, IL-17F and IL-22 in patients with chronic muco-cutaneous candidiasis and auto-immune polyendocrine syndrome type I. J. Exp. Med. 2010, 207:2291-2297.
88. Hong M., et al. Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. Clin. Exp. Immunol. 2009, 156:40-51.